2014

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

mkhanfar, 645, Journal Article, , Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. (2014). Journal of Molecular Modeling, 20, 2080.

2014

). Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease

oaladhami, 719, Journal Article, , ). Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease. (2014). Hypertension, 63, 804-810.

2014

Altered structural and biomechanical properties of mesenteric resistance arteries in a rat model of cystic kidney disease

oaladhami, 719, Journal Article, , Altered structural and biomechanical properties of mesenteric resistance arteries in a rat model of cystic kidney disease. (2014). Journal of Vascular Research 51 (Supplement 2), 115-115, 2014.

2014

Cardiovascular autonomic dysfunction in chronic kidney disease

isalman, 854, Journal Article, , Cardiovascular autonomic dysfunction in chronic kidney disease. (2014). Macquarie University, Faculty of Medicine and Health Sciences, Australian …, 2014.

2014

Development and characterization of 3-(benzylsulfonamido) benzamides as potent and selective SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Development and characterization of 3-(benzylsulfonamido) benzamides as potent and selective SIRT2 inhibitors. (2014). European Journal of Medicinal Chemistry 76, 414-426, 2014, 76, 414–426.

2014

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension

oaladhami, 719, Journal Article, , Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. (2014). American Journal of Physiology-Heart and Circulatory Physiology, 307, H143–H151.

2013

Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling

mkhanfar, 645, Journal Article, , Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling. (2013). Bioorganic & Medicinal Chemistry, 21, 4678–4686.

2013

Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling

mkhanfar, 645, Journal Article, , Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity relationship and pharmacophore modeling. (2013). Bioorganic & Medicinal Chemistry, 21, 4678–4686.

2013

Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity …

mkhanfar, 645, Journal Article, , Protective activity of (1S, 2E, 4R, 6R, 7E, 11E)-2, 7, 11-cembratriene-4, 6-diol analogues against diisopropylfluorophosphate neurotoxicity: Preliminary structure–activity …. (2013). Bioorganic & Medicinal Chemistry 21 (15), 4678-4686, 2013.

2013

Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors

mkhanfar, 645, Journal Article, , Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors. (2013). Journal of Chemical Information and Modeling 53 (10), 2587-2612, 2013, 53, 2587–2612.